Survival differences between activated injectable vitamin D2 and D3 analogs.
Kalantar-Zadeh
K
K
D002117:Calcitriol / Q000627:therapeutic use*; D004872:Ergocalciferols / Q000627:therapeutic use*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000401:mortality; D007676:Kidney Failure, Chronic / Q000150:complications / Q000401:mortality* / Q000628:therapy; D006435:Renal Dialysis / Q000401:mortality
D004872:Ergocalciferols; C042533:1 alpha-hydroxyergocalciferol; C084656:paricalcitol; D002117:Calcitriol